NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
3.13
Dollar change
+0.11
Percentage change
3.64
%
Index- P/E- EPS (ttm)-0.85 Insider Own26.93% Shs Outstand13.72M Perf Week6.46%
Market Cap43.28M Forward P/E- EPS next Y-0.78 Insider Trans0.00% Shs Float10.10M Perf Month10.99%
Enterprise Value21.15M PEG- EPS next Q-0.22 Inst Own29.10% Short Float0.14% Perf Quarter35.50%
Income-9.57M P/S- EPS this Y-16.03% Inst Trans1.94% Short Ratio0.41 Perf Half Y-18.70%
Sales0.00M P/B0.64 EPS next Y14.55% ROA-12.38% Short Interest0.01M Perf YTD-16.31%
Book/sh4.86 P/C1.96 EPS next 5Y- ROE-14.91% 52W High4.97 -36.96% Perf Year7.19%
Cash/sh1.60 P/FCF- EPS past 3/5Y20.89% 44.08% ROIC-14.36% 52W Low1.75 78.86% Perf 3Y-40.04%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility2.96% 4.95% Perf 5Y-88.25%
Dividend TTM- EV/Sales- EPS Y/Y TTM43.88% Oper. Margin- ATR (14)0.14 Perf 10Y-97.77%
Dividend Ex-Date- Quick Ratio11.77 Sales Y/Y TTM- Profit Margin- RSI (14)61.47 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio11.77 EPS Q/Q113.78% SMA205.42% Beta0.72 Target Price11.83
Payout- Debt/Eq0.00 Sales Q/Q- SMA509.57% Rel Volume0.81 Prev Close3.02
Employees- LT Debt/Eq0.00 EarningsJun 23 BMO SMA2002.09% Avg Volume35.31K Price3.13
IPOMay 06, 2011 Option/ShortNo / Yes EPS/Sales Surpr.139.64% - Trades Volume28,627 Change3.64%
Date Action Analyst Rating Change Price Target Change
May-02-25Initiated TD Cowen Buy $12
Sep-01-20Downgrade Oppenheimer Outperform → Perform
Jul-06-20Upgrade B. Riley FBR Neutral → Buy $2
Jan-13-20Downgrade B. Riley FBR Buy → Neutral
Aug-29-19Initiated B. Riley FBR Buy $7.75
Jul-18-19Initiated Oppenheimer Outperform $7
Jun-26-19Initiated H.C. Wainwright Buy $6
Jun-25-25 08:00AM
Jun-23-25 08:00AM
Jun-13-25 08:00AM
Apr-09-25 08:00AM
Mar-11-25 07:00AM
08:00AM Loading…
Feb-25-25 08:00AM
Feb-13-25 08:00AM
Feb-11-25 10:26AM
Feb-10-25 12:05PM
08:05AM
08:01AM
Jan-07-25 08:00AM
Dec-04-24 08:00AM
Nov-13-24 08:00AM
Oct-30-24 08:00AM
08:00AM Loading…
Oct-25-24 08:00AM
Sep-25-24 07:30AM
Sep-20-24 08:35AM
Sep-16-24 12:07PM
Sep-12-24 08:00AM
Sep-05-24 10:35AM
Aug-09-24 02:52PM
08:00AM
Jul-10-24 09:40AM
Jun-27-24 04:05PM
Jun-21-24 01:53PM
08:00AM
Jun-18-24 12:31PM
May-28-24 04:05PM
May-23-24 06:45AM
03:54PM Loading…
Mar-24-24 03:54PM
Feb-12-24 08:00AM
07:57AM
Feb-01-24 08:00AM
Dec-13-23 08:00AM
Nov-13-23 08:20AM
08:00AM
Oct-23-23 08:00AM
Oct-04-23 08:00AM
Sep-26-23 08:00AM
Sep-06-23 08:00AM
Aug-23-23 03:49AM
Aug-22-23 09:19AM
Aug-11-23 07:10AM
07:00AM
Aug-09-23 04:05PM
Jul-28-23 08:02AM
Jul-10-23 09:00AM
Jul-07-23 08:00AM
Jul-05-23 09:00AM
Jun-23-23 07:00AM
Jun-22-23 09:00AM
May-17-23 09:00AM
May-10-23 07:41AM
May-08-23 07:00AM
Apr-04-23 08:01AM
08:00AM
Mar-30-23 08:30AM
06:57AM
Mar-13-23 08:00AM
Mar-08-23 09:00AM
Mar-04-23 08:28AM
Feb-28-23 01:00PM
09:40AM
Feb-15-23 04:02PM
Feb-14-23 07:00AM
Feb-07-23 09:00AM
Jan-25-23 09:00AM
Jan-24-23 04:15PM
Jan-17-23 10:00AM
08:45AM
Jan-13-23 09:00AM
Jan-05-23 09:00AM
Dec-29-22 06:02AM
Dec-28-22 08:00AM
Dec-22-22 08:00AM
Nov-14-22 07:00AM
Nov-09-22 04:15PM
Nov-07-22 04:15PM
Sep-30-22 09:00AM
Sep-29-22 09:00AM
Sep-21-22 08:45AM
Sep-14-22 04:15PM
Sep-13-22 08:00AM
Sep-12-22 09:00AM
Aug-11-22 01:00PM
07:00AM
Aug-02-22 04:15PM
Jul-27-22 08:00AM
Jul-07-22 08:55AM
Jun-22-22 06:10PM
Jun-21-22 08:00AM
Jun-16-22 04:15PM
Jun-14-22 08:00AM
May-23-22 04:15PM
May-18-22 11:20AM
07:30AM
May-16-22 01:30PM
01:20PM
May-12-22 08:00AM
Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.